Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Preclinical Contraceptive Development Program (PCDP)

Overview

Three unwrapped condoms, two wrapped condoms, and a blister pack of birth control pills.The PCDP is a research program formed to expand research leading to the development of male and female contraceptive methods.

The program is funded through the Contraception Research Branch using the exploratory/developmental grant R61/R33 award mechanism.

 

Topic Areas

Research in the PCDP includes preclinical and clinical studies on topics including mechanisms that regulate sperm production, sperm maturation, and sperm agglutination. The program addresses development of both male and female contraceptives.

Other current research topics include:

  • Modulator development of the sperm-specific potassium channel SLO3 for contraception
  • Synthetic mRNA-mediated reversible immunocontraception
  • SMART polymer fibers for tampon-like nonsteroidal contraceptive devices

More Information

NICHD Contacts: Daniel S. Johnston and Leigh Allen

top of page BACK TO TOP